- Home
- FBRX vs NRXS Comparison
FBRX vs NRXS Comparison
Compare FBRX & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBRX
- NRXS
- Stock Information
- Founded
- FBRX N/A
- NRXS 2011
- Country
- FBRX United States
- NRXS United States
- Employees
- FBRX N/A
- NRXS N/A
- Industry
- FBRX Biotechnology: Pharmaceutical Preparations
- NRXS
- Sector
- FBRX Health Care
- NRXS
- Exchange
- FBRX Nasdaq
- NRXS Nasdaq
- Market Cap
- FBRX N/A
- NRXS 20.8M
- IPO Year
- FBRX N/A
- NRXS 2023
- Fundamental
- Price
- FBRX $4.51
- NRXS $2.95
- Analyst Decision
- FBRX Strong Buy
- NRXS
- Analyst Count
- FBRX 3
- NRXS 0
- Target Price
- FBRX $81.25
- NRXS N/A
- AVG Volume (30 Days)
- FBRX 11.8K
- NRXS 6.5K
- Earning Date
- FBRX 11-11-2024
- NRXS 11-18-2024
- Dividend Yield
- FBRX N/A
- NRXS N/A
- EPS Growth
- FBRX N/A
- NRXS N/A
- EPS
- FBRX N/A
- NRXS N/A
- Revenue
- FBRX N/A
- NRXS $2,267,053.00
- Revenue This Year
- FBRX N/A
- NRXS $383.16
- Revenue Next Year
- FBRX N/A
- NRXS N/A
- P/E Ratio
- FBRX N/A
- NRXS N/A
- Revenue Growth
- FBRX N/A
- NRXS N/A
- 52 Week Low
- FBRX $4.44
- NRXS $1.80
- 52 Week High
- FBRX $21.25
- NRXS $3.89
- Technical
- Relative Strength Index (RSI)
- FBRX 22.06
- NRXS 48.76
- Support Level
- FBRX $4.48
- NRXS $2.62
- Resistance Level
- FBRX $5.02
- NRXS $2.97
- Average True Range (ATR)
- FBRX 0.29
- NRXS 0.14
- MACD
- FBRX 0.06
- NRXS -0.00
- Stochastic Oscillator
- FBRX 4.58
- NRXS 59.71
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).